EDHF: an update
M Félétou, PM Vanhoutte - Clinical science, 2009 - portlandpress.com
The endothelium controls vascular tone not only by releasing NO and prostacyclin, but also
by other pathways causing hyperpolarization of the underlying smooth muscle cells. This …
by other pathways causing hyperpolarization of the underlying smooth muscle cells. This …
Endothelium-derived hyperpolarizing factor: where are we now?
M Félétou, PM Vanhoutte - Arteriosclerosis, thrombosis, and …, 2006 - Am Heart Assoc
The endothelium controls vascular tone not only by releasing nitric oxide (NO) and
prostacyclin but also by other pathways causing hyperpolarization of the underlying smooth …
prostacyclin but also by other pathways causing hyperpolarization of the underlying smooth …
EDHF: new therapeutic targets?
M Félétou, PM Vanhoutte - Pharmacological research, 2004 - Elsevier
Besides cyclooxygenase and NO-synthase, another distinct endothelial pathway,
endothelium-dependent hyperpolarization (EDHF), is involved in the relaxation of the …
endothelium-dependent hyperpolarization (EDHF), is involved in the relaxation of the …
Contribution of endothelium‐derived hyperpolarizing factors to the regulation of vascular tone in humans
J Bellien, C Thuillez… - Fundamental & clinical …, 2008 - Wiley Online Library
Endothelium plays a crucial role in the regulation of cardiovascular homeostasis through the
release of vasoactive factors. Besides nitric oxide (NO) and prostacyclin, increasing …
release of vasoactive factors. Besides nitric oxide (NO) and prostacyclin, increasing …
Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease
L Luksha, S Agewall, K Kublickiene - Atherosclerosis, 2009 - Elsevier
The endothelium maintains vascular homeostasis through the release of active vasodilators.
Although nitric oxide (NO) is recognized as the primary factor at level of conduit arteries …
Although nitric oxide (NO) is recognized as the primary factor at level of conduit arteries …
The alternative: EDHF
M Félétou, PM Vanhoutte - Journal of molecular and cellular cardiology, 1999 - Elsevier
Endothelium-dependent relaxations cannot be fully explained by the release of either NO
or/and prostacyclin. Another unidentified substance (s) which hyperpolarizes the underlying …
or/and prostacyclin. Another unidentified substance (s) which hyperpolarizes the underlying …
Endothelium-derived hyperpolarizing factor (s): updating the unknown
JV Mombouli - Trends in Pharmacological Sciences, 1997 - cell.com
Endothelium-dependent hyperpolarization of vascular smooth muscle is a mechanism that
contributes to the vasodilator response to shear stress and chemicals acting on endothelial …
contributes to the vasodilator response to shear stress and chemicals acting on endothelial …
What is new in endothelium-derived hyperpolarizing factors?
WB Campbell, KM Gauthier - Current opinion in nephrology and …, 2002 - journals.lww.com
The chemical identification and functional characterization of endothelium-derived
hyperpolarizing factors varies depending on vascular size, vascular bed and species. Three …
hyperpolarizing factors varies depending on vascular size, vascular bed and species. Three …
Endothelium-derived hyperpolarizing factor
M Félétou, PM Vanhoutte - Vascular Endothelium in Human …, 2003 - taylorfrancis.com
Institut de Recherches Internationale Servier, 6 Place des Pleides, 92415 Courbevoie,
Cedex, FranceINTRODUCTIONEndothelial cells synthesise and release vasoactive …
Cedex, FranceINTRODUCTIONEndothelial cells synthesise and release vasoactive …
From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling
UR Michaelis, I Fleming - Pharmacology & therapeutics, 2006 - Elsevier
Epoxyeicosatrienoic acids (EETs) are generated from arachidonic acid by cytochrome P450
(CYP) epoxygenases. The expression of CYP epoxygenases in endothelial cells is …
(CYP) epoxygenases. The expression of CYP epoxygenases in endothelial cells is …